The Andreani Logistics Group is an Argentinian company started in 1945 in the province of Santa Fe and refounded in 1970 in Buenos Aires, where he managed to develop the largest physical distribution network nationwide, becoming a pioneer and leader in logistics services with high added value.
It comprises four business units in Argentina, Logistics, Pharma, Real Estate Development, and Logistics in Brazil. It also has the Andreani Foundation, through which jointly develops educational and cultural activities in Argentina.
Total installed area: 748,000 m2 total; 283,000 m2 covered
Employees: 6,000 (4,000 in dependent).
Fleet: 1,263 vehicles (Arg and Brazil.) Of different bearing
Turnover projected for 2014: $ 2,250 million pesos
Projected investment in 2014: $ 100 million pesos
Distribution billing business branches: Automotive / Auto Parts: 3%; Cosmetics: 4.5%; Pharmaceutical and Medical Technology: 37%; Machinery and Tools: 7%; Official Bodies: 3%; Financial Services: 11%; Technology and Electros: 5.5%; Telecommunications: 9%; Direct Sales: 3%; Other: 17%.
Commercial portfolio: over 1,000 customers, including highlights Abbott Laboratories, Arcor, Banco Hipotecario, Banco Santander, Bayer, Claro, Farmanet, Godrej Group, Hewlett Packard, Johnson & Johnson Medical, Massalin Special (Philip Morris), Merial, Natura Cosmetics, Nextel, British American Tobacco, Telecom, Telefonica, YPF, among others.
Other strategic investments 2014: Stage construction Norlog scheduled for July 2014 $ 100 million covering 37 hectares (investment Projection complete u $ s 400 million work). Norlog is the main project of Real Estate Development Business Unit, a logistics platform, located on 100 hectares in the northern suburbs of Buenos Aires, for the movement and storage of goods and establishment of light industries.
CONTACT INFO
Grupo Logístico Andreani
Santo Domingo 3220, Ciudad de Buenos Aires
Argentina
+54-0810-122-2345
Pharmaceutical Logistics
Tel .: (011) 5289-6412
Logistics in Brazil
Tel .: (011) 5289 6759 (Buenos Aires, Argentina)
Tel .: (+55 11) 3515-8200 (São Paulo, Brazil) / E-Mail: contato@andreani.com
“Argentina’s health system is in agony” In March 2002, amidst an economic crisis and national healthcare emergency the then Minister of Health Gines Gonzales Garcia declared “Argentina’s health system is…
Santiago Garcia Belmonte, president of Biosidus, discusses how global regulatory trends are driving change in the Argentinian biotech industry, as well the new direction his firm has taken over the…
The Executive Director of Argentina’s social security health provider, PAMI, discusses the institutions mission and evolution, as well as his hopes for the future of the Argentinian health system. What…
Francisco Molinari, CEO of Argentina’s most sophisticated biotech group discusses Argentina’s competitiveness in the global biosimilar market, the current constraints limiting innovation in Argentina, and his company’s recent transition from…
Medtronic’s Regional Director for the South Cone shares with us the story of the company’s impressive success since the rebirth of their Argentinian affiliate in 2007, and indicates that Argentinian…
The national coordinator for Argentina’s ministry of health Plan Remediar discusses developing a professional management culture in the country’s public health centers, and the programs wider role in the public…
Dräger’s Sub Regional manager discusses the challenges of dealing with the fragmented and diverse Argentine healthcare sector, and some of the various strategies and approaches the firm uses to succeed…
The COO of Argentina’s largest logistics provider explains how the firm evolved into the preeminent player in the pharmaceutical logistics market, transporting roughly half of all pharmaceutical and medical device…
Alicia Alvarez Berkenwald, Partner at the specialized intellectual property services firm Berken IP, gives an introduction to the Argentinian IP environment, common strategies used to bypass obstacles, and Berken IP’s…
The vice president of Laboratorio Tuteur highlights the position of his company as the leaders in specialty products in Argentina. Could you please give us an historical overview of Laboratorio…
Founder of Promedon Marcelo Olmedo discusses innovation in Cordoba, and the birth and success of Promedon, a flagship company of the region. How do you see the importance of…
Chagas disease, caused by the protozoan parasite Trypanosoma cruzi, is a potentially life-threatening illness currently afflicting eight to ten million people worldwide. Latin America is home to the vast majority…
See our Cookie Privacy Policy Here
